NCMR is a startup that develops novel therapeutics using regenerative cells. NCMR has been developing regenerative cell-based therapies in the United States for more than 10 years, starting from a technology developed in Japan and improving upon it. By cultivating mesenchymal stem cells harvested from healthy donors, we continue to seek for the first in human medicine for patients suffering from acute stroke with no efficient treatment.

Our mission is to deliver new drugs to patients as soon as possible. To make it possible, we have built a strong network of physicians and research institutions in the U.S. and Japan who are willing to take the initiative in development. In addition, we have been promoting collaboration with partners, including investors, which are essential for startups.

For the time being, we will focus on the development, and will enlarge our body and expand our activities along with the progress.

We look forward to your continued support.

Hiroyuki Mitani, President & CEO